Cargando…
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
Medulloblastoma is the most common malignant tumor that arises from the cerebellum of the central nervous system. Clinically, medulloblastomas are treated by surgery, radiation, and chemotherapy, all of which result in toxicity and morbidity. Recent reports have identified that DDX3, a member of the...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171097/ https://www.ncbi.nlm.nih.gov/pubmed/30292066 http://dx.doi.org/10.1016/j.tranon.2018.09.002 |